NeurologyLive® Friday 5 — May 1, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Click the read more or watch now buttons for more details and information about each highlight.

1: Key Takeaways on Neurorehabilitation Innovation at 2026 AAN: Nirmal Surya, MD, DM

In an interview at AAN 2026, Nirmal Surya, MD, DM, the founder and president of the Indian Federation of Neurorehabilitation, highlighted emerging technologies and evolving therapeutic strategies shaping the future of neurorehabilitation. [WATCH TIME: 5 minutes]

2: Neutrophil-to-Lymphocyte Ratio as a Scalable Signal in Dementia Risk Assessment

In a recent Q&A, Jaime Ramos, PhD, assistant professor of Psychiatry and Neurology at NYU Grossman School of Medicine, discussed the role of neutrophil-to-lymphocyte ratio as a scalable inflammatory marker associated with future dementia risk.

3: Highlights in Movement Disorders From the 2026 AMDAPP Conference: Erin Zinn, MSN, APRN-CNP, ANP-BC, CMRD

In a recent interview, Erin Zinn, MSN, APRN-CNP, ANP-BC, CMRD, the deputy director at Association of Movement Disorder Advanced Practice Providers (AMDAPP), recapped key themes in movement disorders presented at the 2026 AMDAPP conference. [WATCH TIME: 5 minutes]

4: NeuroVoices: Hubert Fernandez, MD, on Tavapadon, TEMPO-4, and Improving Parkinson Disease Management

In our latest NeuroVoices Q&A, Hubert Fernandez, MD, director of the Center for Neurological Restoration at Cleveland Clinic, discussed long-term TEMPO-4 data evaluating tavapadon’s impact on symptom control and levodopa utilization in Parkinson disease.

5: Sex Differences, Hormonal Influences, and Caregiving Burden in Women With Parkinson Disease

In a recent Q&A, experts Sameea Husain, DO, and Sarah Marmol, MD, both of Baptist Health, discussed emerging evidence suggesting that hormonal factors, sex-based clinical differences, and social roles contribute to distinct experiences for women with Parkinson disease.

Don’t have time to read or watch a full video interview? Click here to check out our shorts!